Dyslipidemia and associated factors in patients hospitalized in internal medicine of the Caja Petrolera de Salud of Santa Cruz, Bolivia
DOI:
https://doi.org/10.52428/20756208.v20i48.1241Keywords:
Dislipidemia, hipertrigliceridemia, hipercolesterolemia, enfermedades cardiovasculares, factores de riesgo, estudios transversalesAbstract
Introduction: Cardiovascular diseases (CVD), the leading cause of death globally, are linked to dyslipidemia, a lipid disorder with critical public health implications. This study sought to determine the frequency of dyslipidemia and its associated factors in hospitalized patients. Material and methods: A quantitative, observational, descriptive-cross-sectional study with a deductive approach was conducted from April 29 to May 3, 2024, at the Caja Petrolera de Salud (Petroleum Health Fund) in Santa Cruz, Bolivia. Fifty-seven adult Internal Medicine patients were selected by convenience, following inclusion criteria: age ≥18 years, hospitalization ≥24 hours, and availability of clinical records. Patients with cancer or terminal illnesses were excluded. Data were collected through medical record review and a structured questionnaire validated by experts (Cronbach's α = 0,78). The analysis included descriptive statistics, chi-square test, relative risk (RR), and p-value. Results: Dyslipidemia was present in 35% of cases, with hypertriglyceridemia predominating (50%), followed by a mixed profile (hypertriglyceridemia and hypercholesterolemia) (35%) and hypercholesterolemia (15%). Ninety-five percent were men (relative risk = 24, p < 0,05). Other associated factors included family history (relative risk = 3.6, p < 0,05), obesity (80% of cases), and medication use (65%). Discussion: Dyslipidemia is prevalent in older men and is linked to obesity and pharmacotherapy. Comprehensive preventive strategies are needed.
Downloads
References
Organización Mundial de la Salud. Enfermedades cardiovasculares [Internet]. [consultado el 10 de agosto 2024]. Disponible en: https://www.who.int/es/health-topics/cardiovascular-diseases
Libby P, et al. Atherosclerosis. Nat Rev Dis Primers. [Internet]. 2019 [consultado el 10 de agosto de 2024]; 5(1):56. doi:10.1038/s41572-019-0106-z
https://doi.org/10.1038/s41572-019-0106-z
PMid:31420554
Ference BA, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Eur Heart J. [Internet]. 2017
[consultado el 10 de agosto de 2024]. 38(32):2459-72. doi:10.1093/eurheartj/ehx144
https://doi.org/10.1093/eurheartj/ehx144
PMid:28444290 PMCid:PMC5837225
World Health Organization. Global Health Observatory (GHO) data: cholesterol [Internet]. [consultado el 10 de agosto de 2024]. Disponible en: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/cholesterol.
Kotseva K, et al. EUROASPIRE V: a European Society of Cardiology survey. Eur J Prev Cardiol. [Internet]. 2019
[consultado el 10 de agosto de 2024]. 26(4):394-405. doi:10.1177/2047487318825350
https://doi.org/10.1177/2047487318825350
PMid:30739508
Zhang X, et al. Prevalence of dyslipidemia in Chinese adults: a meta-analysis. Lipids Health Dis. [Internet]. 2018
[consultado el 10 de agosto de 2024]. 17(1):247. doi:10.1186/s12944-018-0895-1
https://doi.org/10.1186/s12944-018-0895-1
PMid:30428934 PMCid:PMC6236929
Anderson TJ, et al. 2016 Canadian Cardiovascular Society Guidelines for Dyslipidemia. Can J Cardiol. [Internet]. 2016
[consultado el 10 de agosto de 2024]. 32(11):1263-82. doi:10.1016/j.cjca.2016.07.510
https://doi.org/10.1016/j.cjca.2016.07.510
PMid:27712954
Roth GA, et al. Global burden of cardiovascular diseases, 1990-2019. J Am Coll Cardiol. [Internet]. 2020
[consultado el 10 de agosto de 2024]. 76(25):2982-3021. doi:10.1016/j.jacc.2020.11.010
https://doi.org/10.1016/j.jacc.2020.11.010
PMid:33309175 PMCid:PMC7755038
Noubiap JJ, et al. Prevalence of dyslipidaemia among adults in Africa. Lancet Glob Health. [Internet]. 2018
https://doi.org/10.1016/S2214-109X(18)30275-4
PMid:30103999
[consultado el 10 de marzo de 2025]. 6(9):e998-e1007. doi:10.1016/S2214-109X(18)30333-6
Gupta R, et al. Cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012
https://doi.org/10.4330/wjc.v4.i4.112
PMid:22558490 PMCid:PMC3342579
[consultado el 10 de marzo de 2025]. 4(4):112-20. doi:10.4330/wjc.v4.i4.112
https://doi.org/10.4330/wjc.v4.i4.112
PMid:22558490 PMCid:PMC3342579
Ponte-Negretti CI, et al. Atherogenic dyslipidemia in Latin America. Int J Cardiol. [Internet]. 2017; [consultado el 10 de marzo de 2025]. 243:516-22. doi:10.1016/j.ijcard.2017.05.059
https://doi.org/10.1016/j.ijcard.2017.05.059
PMid:28552520
Gonzales GF, et al. Cardiovascular disease in the Andean region. Glob Heart. [Internet]. 2019
[consultado el 10 de marzo de 2025]. 14(2):177-85. doi:10.1016/j.gheart.2019.05.003
https://doi.org/10.1016/j.gheart.2019.05.003
PMid:31324368
Gitt AK, et al. Dyslipidemia in patients with acute coronary syndrome in Germany. Clin Res Cardiol. 2015;104(11):969-77. doi:10.1007/s00392-015-0863-y
https://doi.org/10.1007/s00392-015-0863-y
PMid:25956143
Guallar-Castillón P, et al. Prevalence of dyslipidemia among the elderly in Spain. Atherosclerosis. [Internet]. 2015; [consultado el 10 de marzo de 2025]. 240(1):99-105. doi:10.1016/j.atherosclerosis.2015.02.052
https://doi.org/10.1016/j.atherosclerosis.2015.02.052
PMid:25795555 PMCid:PMC4397184
Wu J, et al. Prevalence of dyslipidemia among Chinese adults. Lipids Health Dis. [Internet]. 2019
[consultado el 10 de marzo de 2025]. 18(1):58. doi:10.1186/s12944-019-1006-7
https://doi.org/10.1186/s12944-019-1006-7
PMid:30871555 PMCid:PMC6417088
Benn M, et al. Fam ilial hypercholesterolemia in Denmark. J Clin Endocrinol Metab. [Internet]. 2012
[consultado el 10 de marzo de 2025]. 97(11):3956-64. doi:10.1210/jc.2012-1563
https://doi.org/10.1210/jc.2012-1563
PMid:22893714
Sacks FM, et al. Dietary fats and cardiovascular disease. Circulation. [Internet]. 2017
[consultado el 10 de marzo de 2025]. 136(3):e1-e23. doi:10.1161/CIR.0000000000000510
https://doi.org/10.1161/CIR.0000000000000510
PMid:28620111
Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. [Internet]. 2018
https://doi.org/10.5551/jat.RV17023
PMid:29998913 PMCid:PMC6143775
[consultado el 10 de marzo de 2025] 25(9):771-82. doi:10.5551/jat.RV17023
https://doi.org/10.5551/jat.RV17023
PMid:29998913 PMCid:PMC6143775
Nordestgaard BG. Triglyceride-rich lipoproteins and cardiovascular disease. Circ Res. [Internet]. 2016
https://doi.org/10.1161/CIRCRESAHA.115.306249
PMid:26892957
[consultado el 10 de marzo de 2025] 118(4):547-63. doi:10.1161/CIRCRESAHA.115.306249
https://doi.org/10.1161/CIRCRESAHA.115.306249
PMid:26892957
Klop B, et al. Dyslipidemia in obesity: mechanisms and targets. Nutrients. [Internet] 2013
https://doi.org/10.3390/nu5041218
PMid:23584084 PMCid:PMC3705344
[consultado el 10 de febrero de 2025] 5(4):1218-40. doi:10.3390/nu5041218
https://doi.org/10.3390/nu5041218
PMid:23584084 PMCid:PMC3705344
Rojas R, et al. Metabolic syndrome in Mexican adults. Salud Publica Mex. 2010;52(Suppl 1):S11-S18. doi:10.1590/s0036-36342010000700004
https://doi.org/10.1590/S0036-36342010000700004
PMid:20585723
Correll CU, et al. Cardiometabolic risk of antipsychotics. JAMA. [Internet] 2009
[consultado el 10 de febrero de 2025] 302(16):1765-73. doi:10.1001/jama.2009.1549
https://doi.org/10.1001/jama.2009.1549
PMid:19861668 PMCid:PMC3055794
Serretti A, et al. Side effects of antipsychotics: metabolic syndrome. J Clin Psychopharmacol. [Internet] 2011
[consultado el 10 de febrero de 2025] 31(5):657-66. doi:10.1097/JCP.0b013e31822c0f35
Teslovich TM, et al. Biological relevance of 95 loci for blood lipids. Nature. [Internet] 2010
[consultado el 10 de febrero de 2025] 466(7307):707-13. doi:10.1038/nature09270.
https://doi.org/10.1038/nature09270
PMid:20686565 PMCid:PMC3039276
Weiss LA, et al. The genetics of blood lipid levels. Annu Rev Genomics Hum Genet. [Internet] 2006
[consultado el 10 de febrero de 2025] 7:223-66. doi:10.1146/annurev.genom.7.080505.115606
Benn M, et al. Familial hypercholesterolemia in the Danish population. J Clin Endocrinol Metab. [Internet] 2012 [consultado el 10 de febrero de 2025]; 97(11):3956-64. doi:10.1210/jc.2012-1563
https://doi.org/10.1210/jc.2012-1563
PMid:22893714
Grundy SM, et al. Diagnosis and management of the metabolic syndrome. Circulation. [Internet] 2005
[consultado el 10 de febrero de 2025] 112(17):2735-52. doi:10.1161/CIRCULATIONAHA.105.169404
https://doi.org/10.1161/CIRCULATIONAHA.105.169404
PMid:16157765
Mottillo S, et al. The metabolic syndrome and cardiovascular risk. J Am Coll Cardiol. [Internet] 2010
[consultado el 10 de febrero de 2025] 56(14):1113-32. doi:10.1016/j.jacc.2010.05.034
https://doi.org/10.1016/j.jacc.2010.05.034
PMid:20863953
Aguilar-Salinas CA, et al. Metabolic syndrome in Mexico. Arch Med Res. [Internet] 2003; [consultado el 10 de febrero de 2025] 34(1):1-4. doi:10.1016/s0188-4409(02)00443-4
Townsend N, et al. Cardiovascular disease in Europe: epidemiological update [Internet] 2016. Eur Heart J. 2016
https://doi.org/10.1093/eurheartj/ehw334
PMid:27523477
[consultado el 10 de febrero de 2025] 37(42):3232-45. doi:10.1093/eurheartj/ehw334
https://doi.org/10.1093/eurheartj/ehw334
PMid:27523477

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Javier Rodrigo Llanos Baldivieso, Maria Elena Cespedes Calatayud, Estela Edith Titto Omonte, Adriana Hilary Aguirre Amador

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.